1. Scott CR, Elliot S, Buroker N, et al. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry. J Pediatr. 2013;163(2):498–503.
2. Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, editors. The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2014.
3. Beck M, Arn P, Giugliani R, et al. The natural history of MPS I: global perspectives from the MPS I registry. Genet Med. 2014;16(10):759–65.
4. Clarke L. Mucopolysaccharidosis Type I. In: Pagon RA, Adam MP, Ardinger HH, et al. GeneReviews. Seattle: University of Washington, Seattle; 1993-2018. Available from: URL:
https://www.ncbi.nlm.nih.gov/books/NBK1162/
. Accessed 28 Nov 2018.
5. Terlato NJ, Cox GF. Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature. Genet Med. 2003;5(4):286–94.